(CTXR) Citius Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Citius Pharmaceuticals | (CTXR) share price targets
Complete technical analysis of Citius Pharmaceuticals (CTXR) by charts plus indicators, forecast predictions and share price targets for Citius Pharmaceuticals (CTXR)
Citius Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-19 View latest technical analysis
10 day averaged volume of Citius Pharmaceuticals is 598645
Date | Daily Closing Price | Open | High | Low | Volume |
19 Thu Sep 2024 | 0.55 | 0.54 | 0.58 | 0.52 | 3.131 times |
18 Wed Sep 2024 | 0.51 | 0.50 | 0.52 | 0.50 | 0.694 times |
17 Tue Sep 2024 | 0.50 | 0.51 | 0.53 | 0.50 | 1.158 times |
16 Mon Sep 2024 | 0.50 | 0.51 | 0.53 | 0.49 | 1.254 times |
13 Fri Sep 2024 | 0.52 | 0.52 | 0.53 | 0.51 | 0.903 times |
12 Thu Sep 2024 | 0.52 | 0.53 | 0.54 | 0.51 | 0.899 times |
11 Wed Sep 2024 | 0.53 | 0.54 | 0.54 | 0.48 | 1.134 times |
10 Tue Sep 2024 | 0.54 | 0.55 | 0.55 | 0.52 | 0.811 times |
09 Mon Sep 2024 | 0.52 | 0.53 | 0.55 | 0.51 | 0.851 times |
06 Fri Sep 2024 | 0.53 | 0.54 | 0.57 | 0.52 | 1.449 times |
Stock of Citius Pharmaceuticals (CTXR) has showed a significant upmove. This could be a good time to enter in this stock!
Share price targets for Citius Pharmaceuticals (CTXR)
Target Type | Value |
Downside Target | 0.48 |
Downside Target | 0.49 |
Downside Target | 0.52 |
Downside Target | 0.55 |
Upside Target | 0.58 |
Upside Target | 0.59 |
Upside Target | 0.60 |
Upside Target | 0.68 |
Upside Target | 0.72 |
Upside Target | 0.85 |
Upside Target | 1.03 |
Upside Target | 1.05 |
Intraday share price targets for Citius Pharmaceuticals (CTXR)
Target Type | Value |
Downside Intraday Target | 0.5 |
Downside Intraday Target | 0.45 |
Upside Intraday Target | 0.59 |
Upside Intraday Target | 0.63 |
Downside Intraday Target | 0.54 |
Weekly technical analysis of Citius Pharmaceuticals (CTXR)
Date | Weekly Closing Price | Open | High | Low | Volume |
19 Thu Sep 2024 | 0.55 | 0.51 | 0.58 | 0.49 | 1.356 times |
13 Fri Sep 2024 | 0.52 | 0.53 | 0.55 | 0.48 | 0.989 times |
06 Fri Sep 2024 | 0.53 | 0.58 | 0.59 | 0.52 | 8.976 times |
30 Fri Aug 2024 | 0.57 | 0.57 | 0.59 | 0.56 | 0.068 times |
30 Fri Aug 2024 | 0.57 | 0.60 | 0.68 | 0.56 | 0.777 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Citius Pharmaceuticals (CTXR)
Date | Monthly Closing Price | Open | High | Low | Volume |
19 Thu Sep 2024 | 0.55 | 0.58 | 0.59 | 0.48 | 0.201 times |
30 Fri Aug 2024 | 0.57 | 0.92 | 1.05 | 0.55 | 0.794 times |
31 Wed Jul 2024 | 0.91 | 0.61 | 1.03 | 0.48 | 1.592 times |
28 Fri Jun 2024 | 0.58 | 0.70 | 0.72 | 0.58 | 0.729 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Citius Pharmaceuticals (CTXR)
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Citius Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Citius Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Citius Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Citius Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Citius Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.53 and Citius Pharmaceuticals (CTXR) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Citius Pharmaceuticals (CTXR) stock. Volume based technical analysis of Citius Pharmaceuticals (CTXR) stock is negative.
Citius Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Citius Pharmaceuticals ( (CTXR) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Citius Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Citius Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Citius Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Citius Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Citius Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.53 and Citius Pharmaceuticals (CTXR) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Citius Pharmaceuticals (CTXR) stock. Volume based technical analysis of Citius Pharmaceuticals (CTXR) stock is negative.
Citius Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.